sprite-preloader
Anzeige
Mehr »
Sonntag, 18.02.2018 Börsentäglich über 12.000 News von 579 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrUsing stem cells to generate an immune attack against cancer
FrArbutus, Roivant in talks to launch new RNAi delivery company
FrVertex's nonopioid pain drug clears second phase 2 test
FrSanthera, reeling from DMD blow, lands cystic fibrosis drug
DoBiogen tweaks Alzheimer's phase 3, sparking stock slide
DoGradually eliminating BACE1 clears Alzheimer's mice of amyloid plaque
DoAradigm executives jump ship after FDA snub
DoDIY DNA sequencing for $2 a gene
DoAstellas pledges $102.5M for universal donor cell company
DoBMS makes history with major multibillion-dollar Nektar drug pact
MiMerck BACE1 drug fails in prodromal Alzheimer's phase 3
MiDNAnexus launches NGS-based clinical trial solution
MiNovartis, Gates Foundation pen tropical disease drug pact
MiTetraphase's eravacycline misses endpoints in phase 3 flop
MiMore executive reshuffling at Arcturus as CSO/COO resigns
MiCharles River to acquire MPI Research for $800M
MiErytech doubles down on solid tumor trials for red cell drug therapy
MiBTI files for $69M IPO to run trials in Alzheimer's and cancer
MiKadmon clinical POC data raise expectations for IPF drug
DiBMS taps Sirenas for 'global microbiome' drug discovery
DiMaking inroads toward eliminating HIV
DiAxovant CEO Hung resigns, along with a host of others
DiRoche bispecific antibody tops Lucentis in diabetic eye disease
DiAtlas' I-O startup Surface names CEO with IPO experience
MoArdelyx loses CSO Caldwell as he becomes CEO at a startup